I'm in with an initial position at 76c.
- TAM is sizeable relative to current valuation
- Valuation drivers are both clinical and regulatory
- Strong protected patent position
- Strong balance sheet with circa $33M in cash
- EV of circa $30M, which is very low for a biopharmaceutical company moving into phase 3 trials
- Dr Tom Duthy has a very solid reputation, happy to see him on board as a Director
- Share price currently very low relative to its historical movements and seems to have bottomed out
T.E.P.
I'm in with an initial position at 76c.TAM is sizeable relative...
Add IXC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.7¢ |
Change
0.001(1.32%) |
Mkt cap ! $5.637M | |||
| Open | High | Low | Value | Volume |
| 7.6¢ | 7.7¢ | 7.5¢ | $11.31K | 148.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 62000 | 7.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.2¢ | 83539 | 3 |
View Market Depth
| Last trade - 14.32pm 31/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.6¢ |
Change
0.001 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 7.5¢ | 8.2¢ | 7.5¢ | 76647 | ||
| Last updated 14.46pm 31/05/2024 ? | |||||
| IXC (ASX) Chart |